266 related articles for article (PubMed ID: 34322883)
1. LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC.
Ma L; Xu A; Kang L; Cong R; Fan Z; Zhu X; Huo N; Liu W; Xue C; Ji Q; Li W; Chu Z; Kang X; Wang Y; Sun Z; Han Y; Liu H; Gao X; Han J; You H; Zhao C; Xu X
Hepatology; 2021 Dec; 74(6):3213-3234. PubMed ID: 34322883
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR-383-5p/vesicle-associated membrane protein-2 axis.
Li P; Li Y; Ma L
Pharmacol Res Perspect; 2021 Aug; 9(4):e00815. PubMed ID: 34223709
[TBL] [Abstract][Full Text] [Related]
3. Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression.
Rong Z; Wang Z; Wang X; Qin C; Geng W
J Exp Clin Cancer Res; 2020 Apr; 39(1):61. PubMed ID: 32272940
[TBL] [Abstract][Full Text] [Related]
4. SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback.
Liu S; Bu X; Kan A; Luo L; Xu Y; Chen H; Lin X; Lai Z; Wen D; Huang L; Shi M
Cancer Lett; 2022 Mar; 528():16-30. PubMed ID: 34958891
[TBL] [Abstract][Full Text] [Related]
5. Silenced LINC01134 Enhances Oxaliplatin Sensitivity by Facilitating Ferroptosis Through GPX4 in Hepatocarcinoma.
Kang X; Huo Y; Jia S; He F; Li H; Zhou Q; Chang N; Liu D; Li R; Hu Y; Zhang P; Xu A
Front Oncol; 2022; 12():939605. PubMed ID: 35875091
[TBL] [Abstract][Full Text] [Related]
6. Long intergenic noncoding RNA01134 accelerates hepatocellular carcinoma progression by sponging microRNA-4784 and downregulating structure specific recognition protein 1.
Zheng S; Guo Y; Dai L; Liang Z; Yang Q; Yi S
Bioengineered; 2020 Dec; 11(1):1016-1026. PubMed ID: 32970959
[TBL] [Abstract][Full Text] [Related]
7. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NR2F1-AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR-363.
Huang H; Chen J; Ding CM; Jin X; Jia ZM; Peng J
J Cell Mol Med; 2018 Jun; 22(6):3238-3245. PubMed ID: 29602203
[TBL] [Abstract][Full Text] [Related]
9. Upregulated UCA1 contributes to oxaliplatin resistance of hepatocellular carcinoma through inhibition of miR-138-5p and activation of AKT/mTOR signaling pathway.
Huang G; Li L; Liang C; Yu F; Teng C; Pang Y; Wei T; Song J; Wang H; Liao X; Li Y; Yang J
Pharmacol Res Perspect; 2021 Feb; 9(1):e00720. PubMed ID: 33565716
[TBL] [Abstract][Full Text] [Related]
10. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
12. LncRNA PCGEM1 mediates oxaliplatin resistance in hepatocellular carcinoma via miR-129-5p/ETV1 axis in vitro.
Chen J; Yuan D; Hao Q; Zhu D; Chen Z
Adv Clin Exp Med; 2021 Aug; 30(8):831-838. PubMed ID: 34286514
[TBL] [Abstract][Full Text] [Related]
13. LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5.
Xia C; Sun Y; Li Y; Ma J; Shi J
Sci Rep; 2022 May; 12(1):7826. PubMed ID: 35552451
[TBL] [Abstract][Full Text] [Related]
14. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
Cao F; Yin LX
Exp Mol Pathol; 2019 Feb; 106():34-43. PubMed ID: 30539797
[TBL] [Abstract][Full Text] [Related]
15. Identification of long noncoding RNA expression profile in oxaliplatin-resistant hepatocellular carcinoma cells.
Yin X; Zheng SS; Zhang L; Xie XY; Wang Y; Zhang BH; Wu W; Qiu S; Ren ZG
Gene; 2017 Jan; 596():53-88. PubMed ID: 27729273
[TBL] [Abstract][Full Text] [Related]
16. MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis.
Yu T; Yu J; Lu L; Zhang Y; Zhou Y; Zhou Y; Huang F; Sun L; Guo Z; Hou G; Dong Z; Wang B
Cell Oncol (Dordr); 2021 Aug; 44(4):821-834. PubMed ID: 33974236
[TBL] [Abstract][Full Text] [Related]
17. ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription.
Li K; Gao B; Li J; Chen H; Li Y; Wei Y; Gong D; Gao J; Zhang J; Tan W; Wen T; Zhang L; Huang L; Xiang R; Lin P; Wei Y
Oncotarget; 2015 Nov; 6(35):38107-26. PubMed ID: 26497555
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma.
Xiao J; Lv Y; Jin F; Liu Y; Ma Y; Xiong Y; Liu L; Zhang S; Sun Y; Tipoe GL; Hong A; Xing F; Wang X
Cell Physiol Biochem; 2017; 43(5):1926-1938. PubMed ID: 29055955
[TBL] [Abstract][Full Text] [Related]
19. Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.
Gandhy SU; Imanirad P; Jin UH; Nair V; Hedrick E; Cheng Y; Corton JC; Kim K; Safe S
Oncotarget; 2015 Sep; 6(28):26359-72. PubMed ID: 26317792
[TBL] [Abstract][Full Text] [Related]
20. Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.
Xiu P; Dong X; Dong X; Xu Z; Zhu H; Liu F; Wei Z; Zhai B; Kanwar JR; Jiang H; Li J; Sun X
Cancer Sci; 2013 Mar; 104(3):375-82. PubMed ID: 23279642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
